IQVIA Holdings Inc. (NYSE:IQV) Given Average Rating of “Moderate Buy” by Analysts

Shares of IQVIA Holdings Inc. (NYSE:IQV) have received an average recommendation of “Moderate Buy” from the eighteen analysts that are covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $251.0625.

IQV has been the subject of a number of research reports. Weiss Ratings reiterated a “hold (c)” rating on shares of IQVIA in a report on Thursday, January 22nd. UBS Group boosted their target price on IQVIA from $250.00 to $280.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Hsbc Global Res upgraded shares of IQVIA from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 9th. TD Cowen boosted their price objective on shares of IQVIA from $215.00 to $245.00 and gave the stock a “hold” rating in a report on Thursday, January 22nd. Finally, Morgan Stanley increased their target price on shares of IQVIA from $250.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, December 1st.

IQVIA Price Performance

Shares of NYSE IQV opened at $202.56 on Thursday. The stock’s 50-day simple moving average is $229.85 and its two-hundred day simple moving average is $209.62. IQVIA has a twelve month low of $134.65 and a twelve month high of $247.04. The firm has a market capitalization of $34.50 billion, a P/E ratio of 27.79, a P/E/G ratio of 2.07 and a beta of 1.37. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 2.03.

Institutional Trading of IQVIA

Institutional investors have recently modified their holdings of the company. Independent Advisor Alliance lifted its holdings in IQVIA by 21.9% in the 4th quarter. Independent Advisor Alliance now owns 2,284 shares of the medical research company’s stock worth $515,000 after buying an additional 410 shares during the period. Legacy Financial Advisors Inc. raised its holdings in shares of IQVIA by 16.8% during the fourth quarter. Legacy Financial Advisors Inc. now owns 5,560 shares of the medical research company’s stock valued at $1,253,000 after acquiring an additional 798 shares in the last quarter. Atlantic Union Bankshares Corp lifted its stake in IQVIA by 387.8% in the fourth quarter. Atlantic Union Bankshares Corp now owns 917 shares of the medical research company’s stock worth $207,000 after acquiring an additional 729 shares during the period. World Investment Advisors boosted its holdings in IQVIA by 1.4% in the fourth quarter. World Investment Advisors now owns 81,682 shares of the medical research company’s stock valued at $18,393,000 after acquiring an additional 1,162 shares in the last quarter. Finally, Seelaus Asset Management LLC purchased a new position in IQVIA during the 4th quarter valued at $251,000. 89.62% of the stock is currently owned by hedge funds and other institutional investors.

IQVIA Company Profile

IQVIA (NYSE: IQV) is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. The company combines clinical research capabilities with large-scale health data and analytics to support drug development, regulatory reporting, commercial strategy and real‑world evidence generation. IQVIA traces its current form to the combination of Quintiles and IMS Health announced in 2016 and subsequently rebranded as IQVIA, bringing together long-established clinical research operations and extensive healthcare information assets.

IQVIA’s principal activities include outsourced clinical development services (acting as a contract research organization for phases I–IV), real‑world evidence and observational research, regulatory and safety services, and a suite of technology platforms that enable data integration, analytics and operational management.